دورية أكاديمية
أعرض في EDS

Asthma-associated bacterial infections: Are they protective or deleterious?

التفاصيل البيبلوغرافية
العنوان: Asthma-associated bacterial infections: Are they protective or deleterious?
المؤلفون: Fraga-Silva TFC; Department of Biochemistry and Immunology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil., Boko MMM; Basic and Applied Immunology Program, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil., Martins NS; Basic and Applied Immunology Program, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil., Cetlin AA; Pulmonary Division, Department of Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil., Russo M; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil., Vianna EO; Pulmonary Division, Department of Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil., Bonato VLD; Department of Biochemistry and Immunology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.; Basic and Applied Immunology Program, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
المصدر: The journal of allergy and clinical immunology. Global [J Allergy Clin Immunol Glob] 2022 Sep 20; Vol. 2 (1), pp. 14-22. Date of Electronic Publication: 2022 Sep 20 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918453488706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-8293 (Electronic) Linking ISSN: 27728293 NLM ISO Abbreviation: J Allergy Clin Immunol Glob Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [New York] : Elsevier Inc., [2022]-
مستخلص: Eosinophilic, noneosinophilic, or mixed granulocytic inflammations are the hallmarks of asthma heterogeneity. Depending on the priming of lung immune and structural cells, subjects with asthma might generate immune responses that are T H 2-prone or T H 17-prone immune response. Bacterial infections caused by Haemophilus , Moraxella , or Streptococcus spp. induce the secretion of IL-17, which in turn recruit neutrophils into the airways. Clinical studies and experimental models of asthma indicated that neutrophil infiltration induces a specific phenotype of asthma, characterized by an impaired response to corticosteroid treatment. The understanding of pathways that regulate the T H 17-neutrophils axis is critical to delineate and develop host-directed therapies that might control asthma and its exacerbation episodes that course with infectious comorbidities. In this review, we outline clinical and experimental studies on the role of airway epithelial cells, S100A9, and high mobility group box 1, which act in concert with the IL-17-neutrophil axis activated by bacterial infections, and are related with asthma that is difficult to treat. Furthermore, we report critically our view in the light of these findings in an attempt to stimulate further investigations and development of immunotherapies for the control of severe asthma.
(© 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.)
References: PLoS One. 2015 Dec 15;10(12):e0144840. (PMID: 26669856)
Clin Rev Allergy Immunol. 2015 Feb;48(1):54-65. (PMID: 24399247)
J Immunol. 2009 Aug 1;183(3):1952-63. (PMID: 19570831)
J Infect Dis. 2014 Aug 1;210(3):493-503. (PMID: 24577508)
J Am Acad Dermatol. 2018 May;78(5):872-881.e6. (PMID: 29353025)
Am J Respir Crit Care Med. 2019 Aug 1;200(3):309-317. (PMID: 30875247)
Clin Exp Allergy. 2015 Sep;45(9):1459-71. (PMID: 25944185)
mBio. 2020 Mar 24;11(2):. (PMID: 32209688)
J Immunol. 2013 Oct 15;191(8):4112-20. (PMID: 24048894)
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1294-302. (PMID: 24200404)
Expert Rev Respir Med. 2010 Feb;4(1):71-83. (PMID: 20305826)
Immunobiology. 2015 Feb;220(2):254-61. (PMID: 25245013)
Cell Immunol. 2007 Feb;245(2):103-10. (PMID: 17521621)
Microbiology (Reading). 2006 Feb;152(Pt 2):285-293. (PMID: 16436416)
Can J Physiol Pharmacol. 2009 Oct;87(10):743-55. (PMID: 19898558)
Mucosal Immunol. 2017 Jan;10(1):260-270. (PMID: 27049058)
Nat Rev Microbiol. 2007 Aug;5(8):577-82. (PMID: 17632569)
Front Pediatr. 2019 Jun 18;7:246. (PMID: 31275909)
Front Allergy. 2022 Feb 02;3:806391. (PMID: 35386663)
Ann Allergy Asthma Immunol. 2013 Oct;111(4):268-275.e1. (PMID: 24054362)
Semin Immunol. 2019 Dec;46:101333. (PMID: 31703832)
Chin Med J (Engl). 2017 Mar 20;130(6):730-736. (PMID: 28303858)
Allergy. 2015 Mar;70(3):275-84. (PMID: 25477068)
Nat Rev Immunol. 2013 Feb;13(2):145-9. (PMID: 23348417)
Thorax. 2013 Apr;68(4):322-9. (PMID: 23291349)
Cytokine. 2010 May;50(2):220-7. (PMID: 20194033)
J Mol Med (Berl). 2020 Oct;98(10):1493-1503. (PMID: 32948884)
J Exp Med. 2006 Nov 27;203(12):2715-25. (PMID: 17101734)
N Engl J Med. 2005 May 19;352(20):2082-90. (PMID: 15901861)
BMC Immunol. 2017 Jul 19;18(1):38. (PMID: 28724400)
J Int Med Res. 2005 Sep-Oct;33(5):490-500. (PMID: 16222881)
Cell. 2021 Mar 18;184(6):1469-1485. (PMID: 33711259)
Thorax. 2002 Oct;57(10):875-9. (PMID: 12324674)
Eur Respir J. 2009 Apr;33(4):897-906. (PMID: 19336592)
Mol Immunol. 2018 Sep;101:344-352. (PMID: 30036800)
Thorax. 2012 Jul;67(7):588-99. (PMID: 22387445)
Immunol Invest. 2021 Jul;50(5):544-561. (PMID: 32552227)
J Allergy Clin Immunol. 2019 Nov;144(5):1187-1197. (PMID: 31201890)
Am J Respir Crit Care Med. 2011 May 1;183(9):1153-63. (PMID: 21297073)
Mediators Inflamm. 2019 Mar 17;2019:9050965. (PMID: 31080358)
Mucosal Immunol. 2014 Sep;7(5):1186-98. (PMID: 24549277)
Exp Parasitol. 2015 Sep;156:68-78. (PMID: 26071205)
Microbiome. 2018 Jun 9;6(1):104. (PMID: 29885665)
Int Arch Allergy Immunol. 2005;137 Suppl 1:51-4. (PMID: 15947485)
PLoS One. 2018 Feb 15;13(2):e0192878. (PMID: 29447223)
J Immunol. 2003 Mar 15;170(6):3233-42. (PMID: 12626582)
Clin Immunol. 2013 Jun;147(3):229-41. (PMID: 23269200)
J Allergy Clin Immunol. 2012 Apr;129(4):1000-10.e3. (PMID: 22277204)
Nat Commun. 2019 Dec 16;10(1):5714. (PMID: 31844063)
Exp Lung Res. 2009 Sep;35(7):554-69. (PMID: 19842845)
J Immunol. 1997 Aug 15;159(4):1993-2000. (PMID: 9257866)
Exp Ther Med. 2018 Mar;15(3):2480-2484. (PMID: 29456652)
Curr Opin Immunol. 2018 Oct;54:28-34. (PMID: 29883877)
Am J Respir Crit Care Med. 2014 Nov 15;190(10):1094-101. (PMID: 25162311)
Pediatr Infect Dis. 1983 Jul-Aug;2(4):280-3. (PMID: 6889154)
Nat Rev Immunol. 2018 Feb;18(2):134-147. (PMID: 28990587)
J Infect Dis. 2012 Sep 1;206(5):723-34. (PMID: 22723642)
Clin Exp Allergy. 2012 Jan;42(1):131-43. (PMID: 22093133)
Oncotarget. 2018 May 18;9(38):24898-24913. (PMID: 29861841)
Mediators Inflamm. 2014;2014:257930. (PMID: 24959003)
Thorax. 2000 Aug;55 Suppl 1:S2-10. (PMID: 10943631)
PLoS Pathog. 2011 Oct;7(10):e1002244. (PMID: 21998577)
Front Immunol. 2018 Jun 22;9:1366. (PMID: 29988379)
Nat Immunol. 2015 Jan;16(1):45-56. (PMID: 25521684)
PLoS One. 2015 Mar 27;10(3):e0123010. (PMID: 25816135)
Eur Respir J. 2013 Mar;41(3):716-26. (PMID: 22903959)
Curr Biol. 2006 Feb 21;16(4):401-7. (PMID: 16488875)
Microbiol Immunol. 2017 Feb;61(2):49-56. (PMID: 28225165)
Biochim Biophys Acta. 2011 Nov;1810(11):1066-79. (PMID: 21315804)
Respir Med. 2003 Jun;97(6):726-33. (PMID: 12814161)
Annu Rev Immunol. 2009;27:485-517. (PMID: 19132915)
J Biol Chem. 2014 Jun 20;289(25):17406-15. (PMID: 24802755)
Pharmacol Rep. 2017 Jun;69(3):377-385. (PMID: 28267638)
Am J Physiol Lung Cell Mol Physiol. 2013 Mar 1;304(5):L342-9. (PMID: 23316068)
Eur Respir J. 2016 Mar;47(3):792-800. (PMID: 26647445)
Immunol Cell Biol. 2011 Oct;89(7):777-85. (PMID: 21403663)
Nat Immunol. 2017 Sep 19;18(10):1076-1083. (PMID: 28926539)
Int J Med Sci. 2020 Feb 4;17(4):498-509. (PMID: 32174780)
Clin Immunol. 2017 Oct;183:158-166. (PMID: 28847516)
Trends Immunol. 2017 Dec;38(12):942-954. (PMID: 28784414)
Clin Sci (Lond). 2017 Jun 30;131(14):1723-1735. (PMID: 28667070)
Eur J Pharmacol. 2019 Nov 5;862:172623. (PMID: 31445014)
Eur Respir J. 2011 Jan;37(1):53-64. (PMID: 20525707)
Int Immunopharmacol. 2014 Nov;23(1):316-29. (PMID: 24933589)
Clin Respir J. 2010 Oct;4(4):222-9. (PMID: 20887345)
Ann Allergy Asthma Immunol. 2015 Aug;115(2):103-7. (PMID: 26250770)
J Immunol. 2009 Apr 15;182(8):4507-11. (PMID: 19342622)
N Engl J Med. 2021 Oct 28;385(18):1669-1679. (PMID: 34706172)
Cell Microbiol. 2008 Jul;10(7):1453-67. (PMID: 18363879)
Mucosal Immunol. 2016 Sep;9(5):1288-302. (PMID: 26627460)
Mucosal Immunol. 2015 May;8(3):627-39. (PMID: 25354319)
Respir Res. 2020 Jul 3;21(1):170. (PMID: 32620122)
PLoS One. 2014 Jun 23;9(6):e100645. (PMID: 24955983)
BMC Public Health. 2012 Mar 19;12:204. (PMID: 22429515)
Curr Allergy Asthma Rep. 2013 Oct;13(5):512-7. (PMID: 23934577)
J Immunol. 2008 Mar 1;180(5):3366-74. (PMID: 18292562)
Front Immunol. 2017 Nov 14;8:1562. (PMID: 29184554)
Future Microbiol. 2012 Sep;7(9):1073-100. (PMID: 22953708)
Nat Immunol. 2011 May;12(5):383-90. (PMID: 21502992)
Aging (Albany NY). 2020 Aug 5;12(17):16820-16836. (PMID: 32756014)
Int Arch Allergy Immunol. 2010;151(4):297-307. (PMID: 19844129)
Immunol Lett. 2015 Mar;164(1):44-52. (PMID: 25576460)
Immunol Allergy Clin North Am. 2016 Aug;36(3):483-502. (PMID: 27401621)
Curr Opin Immunol. 2013 Dec;25(6):755-60. (PMID: 24035139)
Thorax. 2010 Dec;65(12):1053-60. (PMID: 20965927)
فهرسة مساهمة: Keywords: IL-17; Severe asthma; bacterial infections; lung inflammation; neutrophil
تواريخ الأحداث: Date Created: 20231002 Latest Revision: 20231030
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10510013
DOI: 10.1016/j.jacig.2022.08.003
PMID: 37780109
قاعدة البيانات: MEDLINE
الوصف
تدمد:2772-8293
DOI:10.1016/j.jacig.2022.08.003